Hudson Bay Capital Management LP Cabaletta Bio, Inc. Transaction History
Hudson Bay Capital Management LP
- $25.7 Billion
- Q2 2025
A detailed history of Hudson Bay Capital Management LP transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 13,070 shares of CABA stock, worth $47,182. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,070
Previous 13,070
-0.0%
Holding current value
$47,182
Previous $19,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
92Shares Held
79.6MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$34.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$31.9 Million0.02% of portfolio
-
Jennison Associates LLC8.5MShares$30.7 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$24.5 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$18.1 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $105M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...